Clearmind Medicine Statistics
Total Valuation
CMND has a market cap or net worth of $4.95 million. The enterprise value is $369,645.
Important Dates
The last earnings date was Thursday, June 12, 2025, after market close.
| Earnings Date | Jun 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CMND has 5.13 million shares outstanding. The number of shares has increased by 220.17% in one year.
| Current Share Class | 5.13M |
| Shares Outstanding | 5.13M |
| Shares Change (YoY) | +220.17% |
| Shares Change (QoQ) | +12.19% |
| Owned by Insiders (%) | 2.88% |
| Owned by Institutions (%) | 4.74% |
| Float | 4.64M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.19 |
| P/TBV Ratio | 2.27 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.74, with a Debt / Equity ratio of 0.02.
| Current Ratio | 1.74 |
| Quick Ratio | 1.68 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -111.11 |
Financial Efficiency
Return on equity (ROE) is -139.17% and return on invested capital (ROIC) is -104.90%.
| Return on Equity (ROE) | -139.17% |
| Return on Assets (ROA) | -52.23% |
| Return on Invested Capital (ROIC) | -104.90% |
| Return on Capital Employed (ROCE) | -254.65% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.21M |
| Employee Count | 4 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CMND has paid $199,703 in taxes.
| Income Tax | 199,703 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -39.10% in the last 52 weeks. The beta is -1.28, so CMND's price volatility has been lower than the market average.
| Beta (5Y) | -1.28 |
| 52-Week Price Change | -39.10% |
| 50-Day Moving Average | 0.95 |
| 200-Day Moving Average | 1.21 |
| Relative Strength Index (RSI) | 50.74 |
| Average Volume (20 Days) | 2,237,431 |
Short Selling Information
The latest short interest is 124,855, so 2.43% of the outstanding shares have been sold short.
| Short Interest | 124,855 |
| Short Previous Month | 105,683 |
| Short % of Shares Out | 2.43% |
| Short % of Float | 2.69% |
| Short Ratio (days to cover) | 1.04 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -5.86M |
| Pretax Income | -6.68M |
| Net Income | -4.83M |
| EBITDA | -5.85M |
| EBIT | -5.86M |
| Earnings Per Share (EPS) | -$1.13 |
Full Income StatementBalance Sheet
The company has $4.65 million in cash and $35,982 in debt, giving a net cash position of $4.61 million or $0.90 per share.
| Cash & Cash Equivalents | 4.65M |
| Total Debt | 35,982 |
| Net Cash | 4.61M |
| Net Cash Per Share | $0.90 |
| Equity (Book Value) | 2.30M |
| Book Value Per Share | 0.45 |
| Working Capital | 2.14M |
Full Balance SheetCash Flow
| Operating Cash Flow | -4.57M |
| Capital Expenditures | n/a |
| Free Cash Flow | -4.57M |
| FCF Per Share | -$0.89 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
